Dr Paul Bielderman joins SurgaColl as Medical Director
We are very pleased to announce the appointment of Dr Paul Bielderman as Medical Director reporting directly to the CEO.
Paul has a long heritage as a physician in the medical industry and has worked in both devices and pharma in a range of Medical Affairs and Medical Director roles, including Covidien (now Medtronic), Kyphon (now Medtronic) and Pfizer.
Paul has a MD, is a specialist Paediatrician, a PhD in Medicine, MBA, BSc and both FARCP and MICR.
Paul’s focus is on the clinical interface and is accountable for medical compliance and vigilance along with a role in designing and executing the company’s Clinical Evidence Programme.